Login / Signup

In vivo electrophysiological study of the targeting of 5-HT 3 receptor-expressing cortical interneurons by the multimodal antidepressant, vortioxetine.

Judith V SchweimerJulia T BrouardYan LiConnie SánchezTrevor Sharp
Published in: The European journal of neuroscience (2022)
The antidepressant vortioxetine has high affinity for the ionotropic 5-HT 3 receptor (5-HT 3 R) as well as other targets including the 5-HT transporter. The procognitive effects of vortioxetine have been linked to altered excitatory:inhibitory balance in cortex. Thus, vortioxetine purportedly inhibits cortical 5-HT 3 R-expressing interneurons (5-HT 3 R-INs) to disinhibit excitatory pyramidal neurons. The current study determined for the first time the effect of vortioxetine on the in vivo firing of putative 5-HT 3 R-INs whilst simultaneously recording pyramidal neuron activity using cortical slow-wave oscillations as a readout. Extracellular single unit and local field potential recordings were made in superficial layers of the prefrontal cortex of urethane-anaesthetised rats. 5-HT 3 R-INs were identified by a short-latency excitation evoked by electrical stimulation of the dorsal raphe nucleus (DRN). Juxtacellular-labelling found such neurons had the morphological and immunohistochemical properties of 5-HT 3 R-INs: basket cell or bipolar cell morphology, expression of 5-HT 3 R-IN markers and parvalbumin-immunonegative. Vortioxetine inhibited the short-latency DRN-evoked excitation of 5-HT 3 R-INs and simultaneously decreased cortical slow wave oscillations, indicative of pyramidal neuron activation. Likewise, the 5-HT 3 R antagonist ondansetron inhibited the short-latency DRN-evoked excitation of 5-HT 3 R-INs. However unlike vortioxetine, ondansetron did not decrease cortical slow-wave oscillations, suggesting a dissociation between this effect and inhibition of 5-HT 3 R-INs. The 5-HT reuptake inhibitor escitalopram had no consistent effect on any electrophysiological parameter measured. Overall, the current findings suggest that vortioxetine simultaneously inhibits (DRN-evoked) 5-HT 3 R-INs and excites pyramidal neurons, thereby changing the excitatory:inhibitory balance in cortex. However, under the current experimental conditions, these two effects were dissociable with only the former likely involving a 5-HT 3 R-mediated mechanism.
Keyphrases
  • major depressive disorder
  • spinal cord
  • working memory
  • binding protein
  • prefrontal cortex
  • risk assessment
  • chronic pain
  • cancer therapy
  • neuropathic pain
  • pain management
  • energy transfer
  • wild type